Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles.
about
The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature ReviewSolid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent BreakthroughsNaringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.Enhanced in Vitro Anti-Tumor Activity of 5-Azacytidine by Entrapment into Solid Lipid Nanoparticles.Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer.Formulation and Physicochemical Characterization of Lycopene-Loaded Solid Lipid NanoparticlesFormulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles.Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility.A comparative histological study on the skin occlusion performance of a cream made of solid lipid nanoparticles and Vaseline.Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer.Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration.Modification of solid lipid nanoparticles loaded with nebivolol hydrochloride for improvement of oral bioavailability in treatment of hypertension: polyethylene glycol versus chitosan oligosaccharide lactate.Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy.
P2860
Q26740190-9E5D7295-13DA-4788-A0A9-01FF9B56AC2BQ26799879-4960BD6F-A61B-44BD-81D6-72C1D10CCC9BQ36657570-F98688CC-6961-4585-8BD6-BB1EEAEA510FQ37352617-71AF9533-9F13-4401-BC38-F1CF6D73176DQ38762630-8EE11794-3FF1-4545-AA9D-2C16018A59EAQ38835753-BC5E3994-CF04-47F0-9BD8-EF49CC6D0290Q38889718-7D67C723-3342-48AB-BEE0-18826C8A73A7Q42827034-142FAF69-0636-4914-8CDF-E41A6F488ABDQ43115608-9D00772B-70CA-4A5A-8B64-3846F8C474DEQ48097759-AA79A39E-367F-47D3-9265-9E8C1AA58F44Q50618289-7DDF88BE-E405-480B-B2F0-0D787EE611ABQ50927252-022904B3-FEB2-4260-9019-AD9DC025E225Q53446106-04A1CA5F-362B-46C8-AC59-DAC70782A1DFQ55241369-6ADFF364-8D8E-462A-AA92-C4245F63E9BB
P2860
Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Formulation, characterization ...... ded solid lipid nanoparticles.
@en
Formulation, characterization ...... ded solid lipid nanoparticles.
@nl
type
label
Formulation, characterization ...... ded solid lipid nanoparticles.
@en
Formulation, characterization ...... ded solid lipid nanoparticles.
@nl
prefLabel
Formulation, characterization ...... ded solid lipid nanoparticles.
@en
Formulation, characterization ...... ded solid lipid nanoparticles.
@nl
P2093
P1476
Formulation, characterization ...... ded solid lipid nanoparticles.
@en
P2093
Hadi Valizadeh
Hamed Hamishehkar
Jafar Ezzati Nazhad Dolatabadi
P356
10.1016/J.COLSURFB.2014.01.055
P577
2014-02-09T00:00:00Z